Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin.

MLA

Marchetti, Piero, et al. “Pancreatic Islets from Type 2 Diabetic Patients Have Functional Defects and Increased Apoptosis That Are Ameliorated by Metformin.” The Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 11, Nov. 2004, pp. 5535–41. EBSCOhost, https://doi.org/10.1210/jc.2004-0150.

APA

Marchetti, P., Del Guerra, S., Marselli, L., Lupi, R., Masini, M., Pollera, M., Bugliani, M., Boggi, U., Vistoli, F., Mosca, F., & Del Prato, S. (2004). Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. The Journal of Clinical Endocrinology and Metabolism, 89(11), 5535–5541. https://doi.org/10.1210/jc.2004-0150

Chicago

Marchetti, Piero, Silvia Del Guerra, Lorella Marselli, Roberto Lupi, Matilde Masini, Maria Pollera, Marco Bugliani, et al. 2004. “Pancreatic Islets from Type 2 Diabetic Patients Have Functional Defects and Increased Apoptosis That Are Ameliorated by Metformin.” The Journal of Clinical Endocrinology and Metabolism 89 (11): 5535–41. doi:10.1210/jc.2004-0150.